210 related articles for article (PubMed ID: 17699251)
1. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality.
Boulware LE; Liu Y; Fink NE; Coresh J; Ford DE; Klag MJ; Powe NR
Clin J Am Soc Nephrol; 2006 May; 1(3):496-504. PubMed ID: 17699251
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in the associations between depressive symptoms, cardiovascular diseases, and all-cause mortality.
Haukkala A; Konttinen H; Uutela A; Kawachi I; Laatikainen T
Ann Epidemiol; 2009 Sep; 19(9):623-9. PubMed ID: 19364664
[TBL] [Abstract][Full Text] [Related]
4. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
Peralta CA; Shlipak MG; Fan D; Ordoñez J; Lash JP; Chertow GM; Go AS
J Am Soc Nephrol; 2006 Oct; 17(10):2892-9. PubMed ID: 16959827
[TBL] [Abstract][Full Text] [Related]
5. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
6. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.
Ng YH; Meyer KB; Kusek JW; Yan G; Rocco MV; Kimmel PL; Benz RL; Beddhu S; Dwyer JT; Toto RD; Eknoyan G; Unruh ML
Am J Kidney Dis; 2006 Apr; 47(4):614-24. PubMed ID: 16564939
[TBL] [Abstract][Full Text] [Related]
9. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
10. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
11. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
Jokinen J; Nordström P
J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
Trivedi H; Xiang Q; Klein JP
Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
14. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
[TBL] [Abstract][Full Text] [Related]
15. The association of depressive symptoms with survival in a Dutch cohort of patients with end-stage renal disease.
Riezebos RK; Nauta KJ; Honig A; Dekker FW; Siegert CE
Nephrol Dial Transplant; 2010 Jan; 25(1):231-6. PubMed ID: 19654227
[TBL] [Abstract][Full Text] [Related]
16. The association of depression with cardiovascular mortality is partly explained by health status. The FINE Study.
Kamphuis MH; Geerlings MI; Giampaoli S; Nissinen A; Grobbee DE; Kromhout D
J Affect Disord; 2009 Apr; 114(1-3):184-92. PubMed ID: 18694600
[TBL] [Abstract][Full Text] [Related]
17. Familiality of cardiovascular mortality in end-stage renal disease patients.
Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
[TBL] [Abstract][Full Text] [Related]
18. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Bradbury BD; Fissell RB; Albert JM; Anthony MS; Critchlow CW; Pisoni RL; Port FK; Gillespie BW
Clin J Am Soc Nephrol; 2007 Jan; 2(1):89-99. PubMed ID: 17699392
[TBL] [Abstract][Full Text] [Related]
19. Preferences for current health and their association with outcomes in patients with kidney disease.
Plantinga LC; Fink NE; Bass EB; Boulware LE; Meyer KB; Powe NR
Med Care; 2007 Mar; 45(3):230-7. PubMed ID: 17304080
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
